Pazopanib Impurities

veeprho banner
Parent Drug Name Name of Impurity Catalogue No.
Pazopanib N-(2-Chloro-4-pyrimidinyl)-2, 3-dimethyl-2H-indazol-6-amine VE009361View CAS 444731-74-2
Pazopanib N-(2-Chloro-4-pyrimidinyl)-N, 2, 3-trimethyl-2H-indazol-6-amine VE009360View CAS 444731-75-3
Pazopanib N-(2-Methoxypyrimidin-4-yl)-N, 2, 3-trimethyl-2H-indazol-6-amine VE009359View CAS 1296888-47-5
Pazopanib Pazopanib N-Desmethyl Impurity VE009201View CAS 1252927-47-1
Pazopanib Pazopanib Regioisomer Impurity VE009371View
Pazopanib 5-Amino-2-methylbenzenesulfonamide VE009202View CAS 9/7/6973

Request a quote

1252927-47-1: Pazopanib N-Desmethyl Impurity

1252927-47-1: Pazopanib N-Desmethyl Impurity
Catalogue No.

VE009201
CAS No.

1252927-47-1
Molecular Formula

C22H22N8
Molecular Weight

398.46 g/mol
Parent drug

Pazopanib
IUPAC Name

5-[[4-[(2, 3-Dimethyl-2H-indazol-6-yl)amino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide
Synonyms

N/A
References

Méndez-Vidal, María José, et al. “Pazopanib: Evidence Review and Clinical Practice in the Management of Advanced Renal Cell Carcinoma.” BMC Pharmacology and Toxicology, vol. 19, no. 1, Nov. 2018, https://doi.org/10.1186/s40360-018-0264-8. ‌
Status

In-stock
ListName

Pazopanib N-Desmethyl Impurity
Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url